Innovations

Drugmaker shares rally on US cancer ruling over Zantac

0

Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.

Refining how doctors assess hypertension risk

Previous article

Webb Telescope reveals distant planet’s atmosphere

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations